Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1); if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b), or due to the Executive’s “Death or Disability” under Section H(2)(c); and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum payment equal to 12 months of Executive’s then-current annual Base Salary; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) (collectively, the “Separation Benefits”).
Appears in 6 contracts
Samples: Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.), Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.), Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)
Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1)H.1; if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b)H.2.b, or due to the Executive’s “Death or Disability” under Section H(2)(c)H.2.c; and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum payment equal to 12 months of Executive’s then-current annual Base Salary; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) H.5 (collectively, the “Separation Benefits”).
Appears in 3 contracts
Samples: Executive Employment Agreement, Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.), Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)
Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1)H.1; if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b)H.2.b, or due to the Executive’s “Death or Disability” under Section H(2)(c)H.2.c; and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum payment equal to 12 months of Executive’s then-current annual Base Salary, to be made not later than 60 days following Executive’s date of termination; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) H.5 (collectively, the “Separation Benefits”).
Appears in 2 contracts
Samples: Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.), Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)
Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1)H.1; if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b)H.2.b, or due to the Executive’s “Death or Disability” under Section H(2)(c)H.2.c; and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum payment equal to 12 months of Executive’s then-current annual Base Salary, to be made not later than 60 days following Executive’s date of Executive’s Initials termination; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) H.5 (collectively, the “Separation Benefits”).
Appears in 1 contract
Samples: Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)
Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1)H.1; if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b)H.2.b, or due to the Executive’s “Death or Disability” under Section H(2)(c)H.2.c; and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum severance payment equal to 12 the sum of (1) twelve (12) months of Executive’s then-'s then current annual Base Salary and (2) the current target bonus percentage of the current annual Base Salary, to be made not later than 60 days following Executive’s date of termination; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) H.5 (collectively, the “Separation Benefits”).
Appears in 1 contract
Samples: Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)
Separation Benefits. If Sucampo terminates Executive’s employment without meeting the conditions for “Termination for Cause” in Section H(1); if Executive resigns for Good Reason under the conditions set forth in Section H(2)(b), or due to the Executive’s “Death or Disability” under Section H(2)(c); and Executive (or the executor of Executive’s estate upon death or incapacity) signs and returns to Sucampo without revocation a release prepared by Sucampo of all legally waivable claims related to or arising from Executive’s employment with Sucampo and all other terms determined exclusively by Sucampo, then (i) Sucampo shall pay Executive (or the estate): (A) the amount of any COBRA continuation premium payments made by Executive during the 12-month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source (whichever comes first); and (B) a lump sum payment equal to the sum of (1) 12 months of Executive’s then-current annual Base Salary and (2) the current target bonus percentage of the current Base Salary; and (ii) Executive’s Equity Incentive Awards shall vest as set forth in Section H(5)(a) (collectively, the “Separation Benefits”).
Appears in 1 contract
Samples: Executive Employment Agreement (Sucampo Pharmaceuticals, Inc.)